NY-ESO-1 157-165 mutant (HLA-A*02:01) 165C

NY-ESO-1 157-165 mutant (HLA-A*02:01) 165C
€50.00 *

Prices plus VAT plus shipping costs

Delivery time approx. 3 weeks

Amount in mg:

make your choice

  • EP11374_1
SLLMWITQC is a linear peptidic epitope (epitope ID59278) studied as part of Cancer/testis antigen... more
Product information "NY-ESO-1 157-165 mutant (HLA-A*02:01) 165C"
SLLMWITQC is a linear peptidic epitope (epitope ID59278) studied as part of Cancer/testis antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays Antigen Peptide NY-ESO-1 157-165 (9C) (HLA-A*02:01) SLLMWITQC for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.SLLMWITQC is a linear peptidic epitope (epitope ID59278) studied as part of Cancer/testis antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays Antigen Peptide NY-ESO-1 157-165 (9C) (HLA-A*02:01) SLLMWITQC for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

 
Sequence:SLLMWITQC
Gene:CTAG1A
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Autoimmunogenic cancer/testis antigen NY-ESO-1
Species:Human
Allele:HLA-A*02:01
Application :Flow Cytometry
Dokumente - Protokolle - Downloads more
Viewed